Copertina

MetaPath Chat: multimodal generative artificial intelligence chatbot for clinical pathology

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Haizhu Chen, Ruichong Lin, Yu Yunfang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	MedComm
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
di: Yunfang Yu, et al.
Pubblicazione: (2024)

The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
di: Venkatachalababu Janitri, et al.
Pubblicazione: (2024)

LungDiag: Empowering artificial intelligence for respiratory diseases diagnosis based on electronic health records, a multicenter study
di: Hengrui Liang, et al.
Pubblicazione: (2025)

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
di: Yunfang Yu, et al.
Pubblicazione: (2025)

Single‐Cell and Spatial Transcriptomics Uncover Immune Dynamics and Cellular Heterogeneity in Benign Prostatic Hyperplasia and Prostate Cancer Transition
di: Yuanyuan Luo, et al.
Pubblicazione: (2026)

The application of the combination between artificial intelligence and endoscopy in gastrointestinal tumors
di: Shen Li, et al.
Pubblicazione: (2024)

CAPability‐01: Success of anti‐PD‐1, HDAC inhibitor, and anti‐VEGF combination in colorectal cancer
di: Yujie Tan, et al.
Pubblicazione: (2024)

Organoids in gastrointestinal diseases: from bench to clinic
di: Qinying Wang, et al.
Pubblicazione: (2024)

Airway stenosis: classification, pathogenesis, and clinical management
di: Pengwei Zhao, et al.
Pubblicazione: (2025)

Radiofrequency ablation: mechanisms and clinical applications
di: Jianhua Wu, et al.
Pubblicazione: (2024)

Endothelial dysfunction: molecular mechanisms and clinical implications
di: Xia Wang, et al.
Pubblicazione: (2024)

Next‐generation spatial transcriptomics: unleashing the power to gear up translational oncology
di: Nan Wang, et al.
Pubblicazione: (2024)

Critical roles and clinical perspectives of RNA methylation in cancer
di: Ganglei Li, et al.
Pubblicazione: (2024)

Targeting esophageal carcinoma: molecular mechanisms and clinical studies
di: Wenjing Wang, et al.
Pubblicazione: (2024)

Sepsis: the evolution of molecular pathogenesis concepts and clinical management
di: Zhongxue Feng, et al.
Pubblicazione: (2025)

Combined pyrotinib and fulvestrant for hormone receptor‐positive and HER2‐positive metastatic breast cancer: A multicenter, single‐arm, phase II trial
di: Jianli Zhao, et al.
Pubblicazione: (2024)

Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
di: Jun He, et al.
Pubblicazione: (2024)

Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
di: Siyu Wang, et al.
Pubblicazione: (2024)

Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
di: Minjin Wang, et al.
Pubblicazione: (2024)

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
di: Junshu Li, et al.
Pubblicazione: (2024)

Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
di: Zhenjun Huang, et al.
Pubblicazione: (2025)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
di: Zhijun Yuan, et al.
Pubblicazione: (2024)

Artificial Intelligence‐Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial
di: Xiatong Huang, et al.
Pubblicazione: (2025)

Alterations in Tryptophan Metabolism and the Indole Pathway in Colorectal Cancer Patients: A Systematic Review and Meta‐analysis
di: Liam Griffith, et al.
Pubblicazione: (2025)

Prevalence, Risk Factors, Lung Function, and Associated Comorbidities of Adult Preserved Ratio Impaired Spirometry: A Meta‐Analysis
di: Haoyu Wang, et al.
Pubblicazione: (2025)

Heavy Metals Toxicity: Mechanism, Health Effects, and Therapeutic Interventions
di: Yu‐feng Cheng, et al.
Pubblicazione: (2025)

Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer
di: Jing Li, et al.
Pubblicazione: (2024)

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B‐Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling
di: Yong Yang, et al.
Pubblicazione: (2025)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
di: TingDan Hu, et al.
Pubblicazione: (2024)

Pulmonary fibrosis: pathogenesis and therapeutic strategies
di: Jianhai Wang, et al.
Pubblicazione: (2024)

Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
di: Zhonghan Zhang, et al.
Pubblicazione: (2024)

First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
di: Wei Du, et al.
Pubblicazione: (2025)

Akebia Saponin D Targeting Ubiquitin Carboxyl‐Terminal Hydrolase 4 Promotes Peroxisome Proliferator‐Activated Receptor Gamma Deubiquitination and Activation of Brown Adipose Tissue Thermogenesis in Obesity
di: Lang Chen, et al.
Pubblicazione: (2025)

Advancing systemic disease diagnosis through ophthalmic image‐based artificial intelligence
di: Hanpei Miao, et al.
Pubblicazione: (2024)

Regulation of bone homeostasis: signaling pathways and therapeutic targets
di: Zebin Wu, et al.
Pubblicazione: (2024)

Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical Managements
di: Yunkui Zhang, et al.
Pubblicazione: (2025)

Clinical Benefit of PD‐1/PD‐L1 Inhibitors as Standard First‐Line Treatment in Low PD‐L1‐Expressing Advanced Solid Tumors: A Systematic Review and Meta‐Analysis
di: Peng Wu, et al.
Pubblicazione: (2026)

Discovery of a Novel Non‐Nucleoside Inhibitor of RNA‐Dependent RNA Polymerase Against Dengue Virus
di: Xue‐Mei He, et al.
Pubblicazione: (2025)

Intravesical Disitamab Vedotin (RC48) for HER2‐Expressing High‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Single‐Arm, Dose–Escalation Phase I Trial Study
di: Xu Chen, et al.
Pubblicazione: (2025)

Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
di: Qian Li, et al.
Pubblicazione: (2024)